Scintipharma, Inc.

About the InteliSite Companion Capsule ...

The InteliSite Companion Capsule is a radiofrequency activated, non-disintegrating drug delivery device. It is capable of non-invasive controlled delivery of drug formulations to the gastrointestinal tract for determining regional differences in drug absorption and bioavailability. A radiolabel included in the drug reservoir permits determination of the capsule location within a specific region of the gastrointestinal tract via gamma scintigraphy. When the capsule reaches the desired location in the gastrointestinal tract, the capsule drug reservoir contents are expelled via an active spring loaded release mechanism. The release, degree of dispersion, and gastrointestinal transit of solution, suspension, powder or solid contents from the capsule can be visualized. Scintipharma personnel were involved in the evaluation and validation, in animals and humans, of prototype capsules.

      A rapid and effective method for determining the rate and extent of drug absorption within specific regions of the GI tract under pharmaceutically and physiologically relevant conditions

      Saves time and avoids waste of resources during the drug development process by defining formulation objectives





InteliSite is a registered trademark of

Casper Associates, P.O. Box 3995, Sanford, NC 27331 USA

[Home] [What is Gamma Scintigraphy?] [Why use Gamma Scintigraphy?] [About the InteliSite capsule] [About Scintipharma]